Mr Mudasir O Arogundade, RPH | |
1451 N Dysart Rd, Avondale, AZ 85323-1515 | |
(623) 925-0280 | |
Not Available |
Full Name | Mr Mudasir O Arogundade |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 1451 N Dysart Rd, Avondale, Arizona |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588995492 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | S009674 (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Mudasir O Arogundade, RPH 1451 N Dysart Rd, Avondale, AZ 85323-1515 Ph: () - | Mr Mudasir O Arogundade, RPH 1451 N Dysart Rd, Avondale, AZ 85323-1515 Ph: (623) 925-0280 |
News Archive
The Georgia Tech College of Computing, working in partnership with the Centers for Disease Control and Prevention, has developed a Web-based tool for tracking blood safety.
A new study finds companies with healthy workforces appear to have a competitive edge in the stock market. The study compared the stock market performance of ten of the healthiest companies in South Africa to the market at large. Nine different investment scenarios were tested and, in all nine scenarios, the healthy companies outperformed the Johannesburg Stock Exchange All Share Index.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has received approximately $9.3 million in strategic financing, as previously announced on January 23, 2012.
Low-income countries "could introduce measures to prevent and treat millions of cases of cancer, heart disease, diabetes and lung disease for a little as $1.20 per person per year, the World Health Organization (WHO) said on Sunday" in a report released on the eve of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York, Reuters reports.
Hematology researchers have used a single injection of gene therapy to correct a rare bleeding disorder, factor VII deficiency, in dogs. This success in large animals holds considerable potential for a safe, effective and long-lasting new treatment in humans with the same bleeding disorder.
› Verified 9 days ago
Brittney Lemming, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1575 N Dysart Rd, Avondale, AZ 85392 Phone: 623-925-0851 | |
Karen Anne Wolfson, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10675 W Indian School Rd, Avondale, AZ 85392 Phone: 623-772-0502 | |
Megan Rhea, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13055 W Rancho Santa Fe Blvd, Avondale, AZ 85392 Phone: 623-935-4022 Fax: 623-935-4149 | |
Dr. Erik Kirakosyan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10350 W Mcdowell Rd Apt 1211, Avondale, AZ 85392 Phone: 323-377-7643 | |
Keri M Romero, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 280 N Avondale Blvd, Avondale, AZ 85323 Phone: 623-882-2021 | |
Caitlin Saunders, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10705 W Indian School Rd, Avondale, AZ 85392 Phone: 623-877-3245 | |
Dr. Heather Bartelt, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1459 N Dysart Rd, Avondale, AZ 85323 Phone: 623-882-3871 Fax: 623-882-3873 |